Canadian Journal of Gastroenterology and Hepatology

Canadian Journal of Gastroenterology and Hepatology / 1997 / Article

Brief Communication | Open Access

Volume 11 |Article ID 203843 | https://doi.org/10.1155/1997/203843

Nir Hilzenrat, Esther Lamoureux, Averell Sherker, Albert Cohen, "Cholestasis in Crohn's Disease: A Diagnostic Challenge", Canadian Journal of Gastroenterology and Hepatology, vol. 11, Article ID 203843, 3 pages, 1997. https://doi.org/10.1155/1997/203843

Cholestasis in Crohn's Disease: A Diagnostic Challenge

Received06 May 1996
Accepted22 May 1996

Abstract

A 24-year-old male with Crohn's disease who developed three independent episodes of cholestatic liver disease over an eight-year period is described. The first episode was related to an idiosyncratic drug reaction while on sulfasalazine. The second episode, at the time of an exacerbation of his colitis, was characterized by moderate portal inflammation on liver biopsy and resolved quickly while he was on corticosteroid therapy. The most recent episode, occurring when the bowel disease was quiescent, was due to granulomatous hepatitis and resolved clinically with no specific therapy. Because numerous potentially serious hepatobiliary complications have been associated with inflammatory bowel disease, prompt and aggressive investigation in these instances is recommended.

Copyright © 1997 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views64
Downloads279
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.